Irreversible cardiotoxicity after adjuvant treatment with trastuzumab in a case of breast cancer.

Bordin, Paolo; Volpe, Carla; Adami, Gianna; Moretti, Valentino; Ermacora, Paola

Bordin, Paolo; Volpe, Carla; Adami, Gianna; Moretti, Valentino; Ermacora, Paola.

Tumori ; 94(5): 777-8, 2008.

Article in En | MEDLINE | ID: mdl-19112961

Subject(s)

Antibodies, Monoclonal/adverse effects; Antineoplastic Agents/adverse effects; Breast Neoplasms/drug therapy; Heart Failure/chemically induced; Heart/drug effects; Ventricular Dysfunction, Left/chemically induced; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal, Humanized; Antineoplastic Agents/administration & dosage; Biomarkers, Tumor/analysis; Breast Neoplasms/chemistry; Female; Heart Failure/physiopathology; Humans; Middle Aged; Receptor, ErbB-2/analysis; Stroke Volume; Trastuzumab; Ventricular Dysfunction, Left/physiopathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Ventricular Dysfunction, Left / Heart / Heart Failure / Antibodies, Monoclonal / Antineoplastic Agents Limits: Female / Humans / Middle aged Language: En Journal: Tumori Year: 2008 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links